Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing only amiloride and furosemide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
Furosemide only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
Product containing only furosemide and potassium (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
Product containing only furosemide and potassium chloride (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
Furosemide and triamterene only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Furosemide (substance) |
Inferred relationship |
Some |
2 |
Product containing only furosemide and spironolactone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Furosemide (substance) |
Inferred relationship |
Some |
2 |
Product containing only furosemide and triamterene in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Furosemide (substance) |
Inferred relationship |
Some |
2 |
Amiloride and furosemide only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
Product containing only furosemide and spironolactone in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Furosemide (substance) |
Inferred relationship |
Some |
2 |
Product containing only furosemide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
Furosemide only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely furosemide 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely furosemide 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
Furosemide 20 mg and spironolactone 50 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Furosemide (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely amiloride hydrochloride 2.5 milligram and furosemide 20 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
Amiloride hydrochloride 10 mg and furosemide 80 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely furosemide 100 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely furosemide 100 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely amiloride hydrochloride anhydrous (as amiloride hydrochloride) 5 milligram and furosemide 40 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Furosemide (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely amiloride hydrochloride anhydrous (as amiloride hydrochloride) 5 milligram and furosemide 40 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Furosemide (substance) |
Inferred relationship |
Some |
2 |